Journal: Oncology Letters
Article Title: lncRNAs are novel biomarkers for differentiating between cisplatin-resistant and cisplatin-sensitive ovarian cancer
doi: 10.3892/ol.2018.8433
Figure Lengend Snippet: Differential lncRNA expression profiles between tissues of cisplatin-resistant and cisplatin-sensitive ovarian cancer. The lncRNA microarray demonstrated the differences between lncRNA expression in cisplatin-resistant and cisplatin-sensitive ovarian cancer through (A) hot-spot and (B) cluster map analysis. (C) Based on the association of the nearby coding genes, the differentially expressed lncRNAs were classified into certain types, including 312 natural antisense, 216 intronic antisense, 114 intron sense-overlapping, 673 intergenic, 201 exon sense-overlapping and 72 bidirectional lncRNA. lncRNA, long non-coding RNA.
Article Snippet: Following washing, the arrays were scanned using the Agilent lncRNA Microarray Scanner (Agilent Technologies, Inc.), and the Agilent Feature Extraction software version 11.0.1.1 (Agilent Technologies, Inc.) was used for microarray probe signal data collection.
Techniques: Expressing, Microarray